(1 - 5 von 6
)
Richard Maziarz, MD: Tisagenlecleucel Induces Durable Response
www.docwirenews.com
Richard Thomas Maziarz, MD, of the Oregon Health & Science Knight Cancer Institute in Portland, presented 19-month follow-up data that ...
sortiert nach Relevanz / Datum